Truvestments Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04K Hold
55
– – ﹤0.01% 900
2026
Q1
$4.69K Buy
+55
New +$4.9K ﹤0.01% 889
2025
Q4
– Sell
-4,974
Closed -$398K – 1059
2025
Q3
$398K Buy
+4,974
New +$424K 0.07% 215
2024
Q1
– Sell
-213
Closed -$17K – 753
2023
Q4
$17K Sell
213
-243
-53% -$18.3K 0.01% 464
2023
Q3
$32.4K Hold
456
– – 0.02% 329
2023
Q2
$35.1K Buy
456
+25
+6% +$1.94K 0.02% 322
2023
Q1
$32.4K Sell
431
-53
-11% -$3.94K 0.02% 334
2022
Q4
$38.1K Buy
+484
New +$36.3K 0.02% 325
2022
Q1
– Sell
-142
Closed -$12K – 249
2021
Q4
$12K Buy
142
+1
+0.7% +$78 0.01% 384
2021
Q3
$11K Hold
141
– – 0.01% 366
2021
Q2
$11K Buy
141
+58
+70% +$4.74K 0.01% 379
2021
Q1
$7K Hold
83
– – ﹤0.01% 483
2020
Q4
$7K Buy
+83
New +$6.86K ﹤0.01% 463
2020
Q3
– Sell
-83
Closed -$6K – 358
2020
Q2
$6K Hold
83
– – 0.01% 447
2020
Q1
$5K Buy
+83
New +$5.85K 0.01% 411

Other funds holding CL

Truvestments Capital's CL Position: Q2 2026 in Review

Truvestments Capital held its Colgate-Palmolive (CL) position steady in Q2 2026 at 55 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Truvestments Capital first reported a position in CL in Q1 2020 and has held it in 15 quarters since. The position peaked at $398K in Q3 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Truvestments Capital held 55 shares of Colgate-Palmolive worth $5.04K as of Q2 2026.
  • Truvestments Capital left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #900 holding.
  • Truvestments Capital first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 15 quarters since.
  • Truvestments Capital's Colgate-Palmolive position peaked at $398K in Q3 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.